KAS
COLL icon

Kemnay Advisory Services’s Collegium Pharmaceutical COLL Stock Holding History

Kemnay Advisory Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,322
Closed -$61.2K – 1218
2025
Q4 		$61.2K Buy
+1,322
New +$55.3K 0.01% 271

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Kemnay Advisory Services's COLL Position: Q1 2026 in Review

Kemnay Advisory Services sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 1,322 shares — an estimated $61.2K sold.

Kemnay Advisory Services first reported a position in COLL in Q4 2025 and held it in 1 quarter. The position peaked at $61.2K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Kemnay Advisory Services reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Kemnay Advisory Services sold 1,322 Collegium Pharmaceutical shares in Q1 2026, an estimated $61.2K.
  • Kemnay Advisory Services first reported a position in Collegium Pharmaceutical in Q4 2025 and held it in 1 quarter.
  • Kemnay Advisory Services's Collegium Pharmaceutical position peaked at $61.2K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.